This is a news story, published by IMR Press, that relates primarily to BCR news.
For more men's health news, you can click here:
more men's health newsFor more news from IMR Press, you can click here:
more news from IMR PressOtherweb, Inc is a public benefit corporation, dedicated to improving the quality of news people consume. We are non-partisan, junk-free, and ad-free. We use artificial intelligence (AI) to remove junk from your news feed, and allow you to select the best health news, business news, entertainment news, and much more. If you like men's health news, you might also like this article about
ovarian radiation doses. We are dedicated to bringing you the highest-quality news, junk-free and ad-free, about your favorite topics. Please come every day to read the latest adjuvant radiotherapy news, Ovary radiation exposure news, men's health news, and other high-quality news about any topic that interests you. We are working hard to create the best news aggregator on the web, and to put you in control of your news feed - whether you choose to read the latest news through our website, our news app, or our daily newsletter - all free!
breast cancer radiotherapyIMR Press
•81% Informative
Ovary radiation exposure during breast cancer radiotherapy ( BCR ) may cause concern in patients and obstetricians.
In this study, ovarian doses in adjuvant radiotherapy of breast cancer patients who received RT with the 3D technique were zero .
In patients with MRM , ipsilateral ovary dose in helical IMRT plans was median 10 (range 1013); in patients with BCS , it was median 15 (1230) cGy.
VR Score
93
Informative language
98
Neutral language
79
Article tone
formal
Language
English
Language complexity
54
Offensive language
not offensive
Hate speech
not hateful
Attention-grabbing headline
not detected
Known propaganda techniques
not detected
Time-value
long-living
External references
no external sources
Source diversity
no sources
Affiliate links
no affiliate links